Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
2(33%)
Results Posted
100%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_1
2
33%
Ph phase_2
2
33%
Ph phase_3
2
33%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Not yet recruiting1
Recruiting1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
33.3%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 22 (33.3%)
Phase 32 (33.3%)

Trials by Status

not_yet_recruiting117%
recruiting117%
terminated233%
completed117%
active_not_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
completedphase_1

EBRT + Lu-PSMA for N1M0 Prostate Cancer

NCT05162573
recruitingphase_2

Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer

NCT05687851
active_not_recruitingphase_3

A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer

NCT05235516
terminatedphase_1

A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

NCT04957290
not_yet_recruitingphase_2

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

NCT05489848
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05162573Phase 1

EBRT + Lu-PSMA for N1M0 Prostate Cancer

Completed
NCT05687851Phase 2

Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer

Recruiting
NCT05235516Phase 3

A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer

Active Not Recruiting
NCT04957290Phase 1

A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

Terminated
NCT05489848Phase 2

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

Not Yet Recruiting
NCT02773966Phase 3

Kypho-IORT vs. EBRT in Spinal Metastases

Terminated

All 6 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
6